{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:27:06Z","timestamp":1794652026264,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>Alpha-inhibin expression has been reported in pheochromocytomas and paragangliomas (PPGLs). We analyzed alpha-inhibin immunohistochemistry in 77 PPGLs (37 pheochromocytomas [PCCs] and 40 paragangliomas) and correlated the results with catecholamine profile, tumor size, Ki-67 labeling index, succinate dehydrogenase B subunit and carbonic anhydrase IX (CAIX) staining, and genetic pathogenesis. PPGLs were classified as pseudohypoxic cluster 1 disease with documented <jats:italic toggle=\"yes\">VHL<\/jats:italic> mutation or <jats:italic toggle=\"yes\">SDHx<\/jats:italic> mutation or biochemical phenotype, whereas <jats:italic toggle=\"yes\">NF1<\/jats:italic>-driven and <jats:italic toggle=\"yes\">RET<\/jats:italic>-driven PPGLs and those with a mature secretory (adrenergic or mixed adrenergic and noradrenergic) phenotype were classified as cluster 2 disease. The Cancer Genome Atlas data on <jats:italic toggle=\"yes\">INHA<\/jats:italic> expression in PPGLs was examined. Alpha-inhibin was positive in 43 PPGLs (56%). Ki-67 labeling indices were 8.07% and 4.43% in inhibin-positive and inhibin-negative PPGLs, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). Alpha-inhibin expression did not correlate with tumor size. Alpha-inhibin was expressed in 92% of <jats:italic toggle=\"yes\">SDHx<\/jats:italic>-related and 86% of <jats:italic toggle=\"yes\">VHL<\/jats:italic>-related PPGLs. CAIX membranous staining was found in 8 of 51 (16%) tumors, including 1 <jats:italic toggle=\"yes\">SDHx<\/jats:italic>-related PCC and all 5 <jats:italic toggle=\"yes\">VHL<\/jats:italic>-related PCCs. <jats:italic toggle=\"yes\">NF1<\/jats:italic>-driven and <jats:italic toggle=\"yes\">RET<\/jats:italic>-driven PPGLs were negative for alpha-inhibin and CAIX. Alpha-inhibin was expressed in 77% of PPGLs with a pseudohypoxia signature, and 20% of PPGLs without a pseudohypoxia signature (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). PPGLs with a mature secretory phenotype were negative for CAIX. The Cancer Genome Atlas data confirmed higher expression of <jats:italic toggle=\"yes\">INHA<\/jats:italic> in cluster 1 than in cluster 2 PPGLs. This study identifies alpha-inhibin as a highly sensitive (90.3%) marker for <jats:italic toggle=\"yes\">SDHx\/VHL<\/jats:italic>-driven pseudohypoxic PPGLs. Although CAIX has low sensitivity, it is the most specific biomarker of <jats:italic toggle=\"yes\">VHL<\/jats:italic>-related pathogenesis. While alpha-inhibin cannot replace succinate dehydrogenase B subunit immunohistochemistry for detection of <jats:italic toggle=\"yes\">SDHx<\/jats:italic>-related disease, it adds value in prediction of cluster 1 disease. Importantly, these data emphasize that alpha-inhibin is not a specific marker of adrenal cortical differentiation, as it is also expressed in PCCs.<\/jats:p>","DOI":"10.1097\/pas.0000000000001715","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:06:42Z","timestamp":1617840402000},"page":"1264-1273","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":39,"title":["Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas"],"prefix":"10.1097","volume":"45","author":[{"given":"Ozgur","family":"Mete","sequence":"first","affiliation":[{"name":"Department of Pathology, University Health Network"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"Endocrine Oncology Site, The Princess Margaret Cancer Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pakbaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Health Network"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Lerario","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Giordano","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes"},{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of pediatric vs adult pheochromocytomas and paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12020-017-1310-9","article-title":"Routine genetic screening with a multi-gene panel in patients with pheochromocytomas","volume":"59","author":"Sbardella","year":"2018","journal-title":"Endocrine"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-018-9555-2","article-title":"The role of immunohistochemistry and molecular analysis of succinate dehydrogenase in the diagnosis of endocrine and non-endocrine tumors and related syndromes","volume":"30","author":"Oudijk","year":"2019","journal-title":"Endocr Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12022-012-9195-x","article-title":"From transcriptional profiling to tumor biology in pheochromocytoma and paraganglioma","volume":"23","author":"Casc\u00f3n","year":"2012","journal-title":"Endocr Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-012-9199-6","article-title":"Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies","volume":"23","author":"N\u00f6lting","year":"2012","journal-title":"Endocr Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12022-011-9188-1","article-title":"Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification","volume":"23","author":"Eisenhofer","year":"2012","journal-title":"Endocr Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/jcm7090280","article-title":"The diagnosis and clinical significance of paragangliomas in unusual locations","volume":"7","author":"Asa","year":"2018","journal-title":"J Clin Med"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","journal-title":"Clin Chem"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5858\/arpa.2012-0551-OA","article-title":"Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas","volume":"138","author":"Mete","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"R13-20250608","first-page":"246","article-title":"Hereditary endocrine tumor syndromes: the clinical and predictive role of molecular histopathology","volume":"22","author":"Duan","year":"2017","journal-title":"AJSP Rev Rep"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.humpath.2009.12.005","article-title":"Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes","volume":"41","author":"Gill","year":"2010","journal-title":"Hum Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12022-018-9534-7","article-title":"Old, new and emerging immunohistochemical markers in pheochromocytoma and paraganglioma","volume":"29","author":"Cheung","year":"2018","journal-title":"Endocr Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/bjc.2012.538","article-title":"Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations","volume":"108","author":"Pinato","year":"2013","journal-title":"Br J Cancer"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","article-title":"Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study","volume":"33","author":"Favier","year":"2020","journal-title":"Mod Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12022-016-9460-5","article-title":"Pathological and genetic characterization of bilateral adrenomedullary hyperplasia in a patient with germline MAX mutation","volume":"28","author":"Romanet","year":"2017","journal-title":"Endocr Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2017.10.013","article-title":"The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes","volume":"71","author":"Udager","year":"2018","journal-title":"Hum Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00428-013-1465-6","article-title":"Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease","volume":"463","author":"Gucer","year":"2013","journal-title":"Virchows Arch"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/00000478-200110000-00017","article-title":"Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease","volume":"25","author":"Sinkre","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAI.0b013e318239e18d","article-title":"Diagnostic role of inhibin \u03b1-subunit and inhibin\/activin \u03b2-subunit in adrenal cortical and medullary tumors in Egyptian patients","volume":"20","author":"Elmoneim","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00129039-200109000-00005","article-title":"Immunoexpression of inhibin alpha-subunit in adrenal neoplasms","volume":"9","author":"Cho","year":"2001","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R27-20250608","first-page":"516","article-title":"The alpha subunit of inhibin in adrenal cortical neoplasia","volume":"11","author":"Pelkey","year":"1998","journal-title":"Mod Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0b013e3181cfb506","article-title":"A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma","volume":"34","author":"Sangoi","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.MP.0000073134.60541.E8","article-title":"The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study","volume":"16","author":"Zhang","year":"2003","journal-title":"Mod Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jcp.51.2.114","article-title":"Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin","volume":"51","author":"McCluggage","year":"1998","journal-title":"J Clin Pathol"},{"key":"R31-20250608","first-page":"905","article-title":"Inhibin alpha-subunit, Melan A and MNF116 in pheochromocytomas","volume":"55","author":"P\u0103un","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1677\/joe.0.1650223","article-title":"Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm","volume":"165","author":"Arola","year":"2000","journal-title":"J Endocrinol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00000478-198706000-00009","article-title":"Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors","volume":"11","author":"Ramsay","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/EP:13:1:17","article-title":"Pheochromocytoma in von Hippel-Lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2","volume":"13","author":"Koch","year":"2002","journal-title":"Endocr Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2265.2007.02732.x","article-title":"Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry","volume":"66","author":"Hofland","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical biomarkers of adrenal cortical neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12022-020-09624-3","article-title":"Immunohistochemical analysis of the metabolic phenotype of adrenal cortical carcinoma","volume":"31","author":"Duan","year":"2020","journal-title":"Endocr Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/path.5402","article-title":"Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue-based research","volume":"250","author":"Macklin","year":"2020","journal-title":"J Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1593\/neo.122132","article-title":"Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas","volume":"15","author":"Shankavaram","year":"2013","journal-title":"Neoplasia"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neo.2016.07.008","article-title":"Hypoxia-inducible factor 2\u03b1 mutation-related paragangliomas classify as discrete pseudohypoxic subcluster","volume":"18","author":"Fliedner","year":"2016","journal-title":"Neoplasia"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000457479","article-title":"Hypoxia pathway mutations in pheochromocytomas and paragangliomas","volume":"150","author":"Amorim-Pires","year":"2016","journal-title":"Cytogenet Genome Res"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","article-title":"Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am J Hum Genet"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1210\/jc.2019-01101","article-title":"Metabolomic urine profile: searching for new biomarkers of SDHx-associated pheochromocytomas and paragangliomas","volume":"104","author":"Martins","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neo.2014.10.010","article-title":"Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications","volume":"17","author":"Imperiale","year":"2015","journal-title":"Neoplasia"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2014-2151","article-title":"Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency","volume":"99","author":"Richter","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.5472","article-title":"Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas","volume":"251","author":"Wallace","year":"2020","journal-title":"J Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"Lopez-Jimenez","year":"2010","journal-title":"Mol Endocrinol"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"19431","DOI":"10.1074\/jbc.M401235200","article-title":"Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase\/AKT\/Ras homolog enriched in brain (Rheb)\/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation","volume":"279","author":"Alam","year":"2004","journal-title":"J Biol Chem"},{"key":"R52-20250608","first-page":"199","article-title":"HIF1A and EPAS1 potentiate hypoxia-induced upregulation of inhibin alpha chain expression in human term cytotrophoblasts in vitro","volume":"23","author":"Depoix","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5858\/arpa.2013-0520-RS","article-title":"Endocrine manifestations of von Hippel-Lindau disease","volume":"139","author":"Cassol","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PAS.0000000000001415","article-title":"Morphologic clues to succinate dehydrogenase (SDH) deficiency in pheochromocytomas and paragangliomas","volume":"44","author":"Turchini","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12022-013-9269-4","article-title":"Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas","volume":"24","author":"Castelblanco","year":"2013","journal-title":"Endocr Pathol"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"805","DOI":"10.21873\/anticanres.11381","article-title":"Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation","volume":"37","author":"Santi","year":"2017","journal-title":"Anticancer Res"},{"key":"R57-20250608","first-page":"148","article-title":"Positive immunostaining for succinate dehydrogenase B (SDHB) in paraganglioma associated with germline mutation of SDHB, L157X and P236S","volume":"45","author":"Sato","year":"2020","journal-title":"Tokai J Exp Clin Med"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:06:15Z","timestamp":1749416775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001715","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,7]]}}}